The Evolutionary Function of Shame" Explores Transgender Identity and Scientific Ethics
D.A. Mindell's "The Evolutionary Function of Shame," premiering February 12th at Second Stage Theater's Next Stage Festival, explores the relationship between a transgender man and his identical twin sister, a geneticist, highlighting ethical concerns in scientific research and its impact on the tra...
The Evolutionary Function of Shame" Explores Transgender Identity and Scientific Ethics
D.A. Mindell's "The Evolutionary Function of Shame," premiering February 12th at Second Stage Theater's Next Stage Festival, explores the relationship between a transgender man and his identical twin sister, a geneticist, highlighting ethical concerns in scientific research and its impact on the tra...
Progress
32% Bias Score
Study: Gender-Affirming Care for Transgender Youth in US Far Less Common Than Perceived
A new analysis of nearly 5.2 million US adolescents (2018-2022) shows that prescriptions of puberty blockers and gender-affirming hormones for transgender youth are rare; only 20.81 per 100,000 biologically female teens received puberty blockers, and 49.9 per 100,000 received hormones, challenging p...
Study: Gender-Affirming Care for Transgender Youth in US Far Less Common Than Perceived
A new analysis of nearly 5.2 million US adolescents (2018-2022) shows that prescriptions of puberty blockers and gender-affirming hormones for transgender youth are rare; only 20.81 per 100,000 biologically female teens received puberty blockers, and 49.9 per 100,000 received hormones, challenging p...
Progress
40% Bias Score
U.K. Indefinitely Bans New Puberty Blocker Prescriptions for Transgender Minors
The U.K. indefinitely banned new puberty blocker prescriptions for transgender minors due to insufficient evidence of benefits and safety concerns, following an independent review; existing users can continue treatment, and the ban will be revisited in 2027.
U.K. Indefinitely Bans New Puberty Blocker Prescriptions for Transgender Minors
The U.K. indefinitely banned new puberty blocker prescriptions for transgender minors due to insufficient evidence of benefits and safety concerns, following an independent review; existing users can continue treatment, and the ban will be revisited in 2027.
Progress
60% Bias Score
UK Bans Puberty Blockers for Gender Dysphoria
The British government indefinitely banned puberty blockers for children with gender dysphoria due to safety concerns, reversing previous practices and contradicting international medical standards; a clinical trial is planned for 2024.
UK Bans Puberty Blockers for Gender Dysphoria
The British government indefinitely banned puberty blockers for children with gender dysphoria due to safety concerns, reversing previous practices and contradicting international medical standards; a clinical trial is planned for 2024.
Progress
56% Bias Score
Trans Man's Isolation Highlights Underwear Accessibility Crisis
A 28-year-old trans man from Wales, Jay-Harley Rees, describes hiding himself away every month due to a lack of access to trans-friendly underwear, highlighting the need for inclusivity and the significant mental health challenges faced by the transgender community in small towns and rural areas.
Trans Man's Isolation Highlights Underwear Accessibility Crisis
A 28-year-old trans man from Wales, Jay-Harley Rees, describes hiding himself away every month due to a lack of access to trans-friendly underwear, highlighting the need for inclusivity and the significant mental health challenges faced by the transgender community in small towns and rural areas.
Progress
44% Bias Score
UK Bans Puberty Blockers for Minors Amidst Growing European Concerns
The United Kingdom has banned puberty blockers for children under 18, joining other Western European nations restricting access amid concerns about long-term effects and insufficient evidence of efficacy; this follows a temporary ban and challenges the previously accepted "Dutch protocol."
UK Bans Puberty Blockers for Minors Amidst Growing European Concerns
The United Kingdom has banned puberty blockers for children under 18, joining other Western European nations restricting access amid concerns about long-term effects and insufficient evidence of efficacy; this follows a temporary ban and challenges the previously accepted "Dutch protocol."
Progress
52% Bias Score
UK Indefinitely Bans Puberty Blockers for Children
The UK government has indefinitely banned puberty blockers for children due to safety concerns raised by the Commission on Human Medicines, following an independent review that found insufficient evidence to support their use and concerns about informed consent. The ban will be reviewed in 2027.
UK Indefinitely Bans Puberty Blockers for Children
The UK government has indefinitely banned puberty blockers for children due to safety concerns raised by the Commission on Human Medicines, following an independent review that found insufficient evidence to support their use and concerns about informed consent. The ban will be reviewed in 2027.
Progress
64% Bias Score
UK Indefinitely Bans Puberty Blockers for Under-18s
The UK government has indefinitely banned puberty blockers for under-18s with gender dysphoria due to safety concerns raised by the Commission on Human Medicines and the Cass Review, impacting access to these treatments across the UK and prompting a future clinical trial.
UK Indefinitely Bans Puberty Blockers for Under-18s
The UK government has indefinitely banned puberty blockers for under-18s with gender dysphoria due to safety concerns raised by the Commission on Human Medicines and the Cass Review, impacting access to these treatments across the UK and prompting a future clinical trial.
Progress
60% Bias Score